Brainomix | e-MRI

Brainomix 360 e-MRI: Supporting Advanced Imaging Assessments

Magnetic Resonance Imaging (MRI) can be used to inform treatment decisions for acute ischemic stroke patients, particularly when assessing eligibility of late-window patients for thrombolysis and thrombectomy.

Brainomix 360 e-MRI is an FDA-cleared and European MDR-certified visualization and processing tool, providing both analysis and viewing capabilities for Diffusion Weighted Imaging (DWI), DWI-FLAIR mismatch, and Dynamic Susceptibility Contrast (DSC) perfusion, allowing for side-by-side viewing of different MR sequences along with results.

The platform processes DWI scans to generate Apparent Diffusion Coefficient (ADC) maps and includes automated algorithms for both DWI-FLAIR mismatch analysis and restricted diffusion mapping, as well as comprehensive perfusion analysis with mismatch volume and multi-threshold parameter maps.

A Multi-Vendor Solution for MRI

The tool can process DWI scans to generate an Apparent Diffusion Coefficient (ADC) map. An automated algorithm then processes DWI and ADC images to generate a mask where low ADC values are displayed with a computed volume - indicating areas likely to contain restricted diffusion. ADC, bmax, b0, and the ADC mask are displayed side-by-side for ease of viewing.

e-MRI can also process DSC MR volumes to compute standard perfusion parameters, using a robust, delay-insensitive deconvolution algorithm. Outputs include: